- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
What is the Potential Role of Injectable Platelet-Rich Fibrin in Dentistry?
Researchers have found in a new research that injectable Platelet-Rich Fibrin (i-PRF) may have a significant role in dentistry, potentially enhancing both soft and hard tissue regeneration. This study was conducted by Unnati S. and colleagues published in the journal JMIR Research Protocols. i-PRF increases the levels of collagen, transforming growth factor β (TGF-β), and PDGF, which makes it a bioactive agent capable of regenerating soft and hard periodontal tissues.
The researchers will search electronically through six major databases: PubMed, Cochrane Library, Google Scholar, Semantic Scholar, Scopus, and Web of Science. Inclusion criteria include only RCTs published in English, which compare i-PRF with other biomaterials for periodontal regeneration. Manual searches will also be carried out through the relevant references. Study selection, data extraction, and risk assessment will be done independently by two reviewers using the Risk of Bias 2 tool.
Key Findings
Databases: A comprehensive database search will be conducted for the research.
Outcomes of Interest: The criteria for evaluation involve mean differences in clinical measures including:
• Gingival Recession: Changes after treatment.
• Probing Pocket Depth: Change following intervention.
• Clinical Attachment Level: Restoration of periodontal structures.
• Bone Gain: Increase in bone density at the affected areas.
• Gingival Width: Soft tissue regeneration results.
• Timeframe: The synthesis started in October 2023 and will end by December 2025.
• Statistical Model: The combined effect sizes and 95% CIs will be estimated using a random-effects model.
The planned systematic review will assess clinical measures to determine i-PRF's place in routine periodontal treatment. i-PRF could revolutionize periodontal therapy by enhancing soft and hard tissue regeneration. This study aims to provide robust evidence for its clinical application, paving the way for improved patient outcomes in dentistry.
Reference:
Shirbhate U, Bajaj P, Wanjari M, Patil M. Role of Injectable Platelet-Rich Fibrin in the Management of Soft and Hard Tissue Periodontal Regeneration in Dentistry: Protocol for a Systematic Review. JMIR Res Protoc. 2025 Jan 23;14:e65137. doi: 10.2196/65137. PMID: 39847766.
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751